PEER REVIEWED RESEARCH ARTICLES, 2015-2017
Konar M, and Granoff DM. Eculizumab blocks vaccine-induced opsonophagocytic killing of meningococci by whole blood from immunized adults. Blood. 2017;Jun 19. doi:10.1182/blood-2017-05-781450. [Epub ahead of print]. PubMed ID: 28630122.
Lujan E, Winter K, Rovaris J, Liu Q, and Granoff DM. Serum bactericidal antibody responses of students immunized with a meningococcal serogroup B vaccine in response to an outbreak on a university campus. Clinical Infectious Diseases 2017;
Lujan E, Partridge E, Giuntini S, Ram S, and Granoff DM. Breadth and duration of meningococcal serum bactericidal activity in healthcare workers and microbiologists immunized with the MenB-FHbp vaccine. Clinical Vaccine and Immunology 2017; doi:10.1128/CVI.00121-17. [Epub ahead of print]. PubMed ID: 28566335.
Giuntini S, Lujan E, Gibani MM, Dold C, Rollier CS, Pollard AJ and Granoff DM. Serum bactericidal antibody responses of adults immunized with the MenB-4C vaccine against genetically diverse serogroup B meningococci. Clinical Vaccine and Immunology 2017;5:e00430. PubMed ID: 27847367.
Giuntini S, Granoff DM, Beernink PT, Ihle O, Bratlie D, and Michaelsen TE. Human IgG1, IgG3, and IgG3 hinge-truncated mutants show different protection capabilities against meningococci depending on the target antigen and epitope specificity. Clinical Vaccine and Immunology 2016;23:698-706. PubMed ID: 27307451.
Pajon R, Lujan E, and Granoff DM. A meningococcal NOMV-FHbp vaccine for Africa elicits broader serum bactericidal antibody responses against serogroup B and non-B strains than a licensed serogroup B vaccine. Vaccine 2016;34:643-649.
Giuntini S, Beernink PT, and Granoff DM. Effect of complement Factor H on anti-FHbp serum bactericidal antibody responses of infant rhesus macaques boosted with a licensed meningococcal serogroup B vaccine. Vaccine 2015;33:7168-7175. PubMed ID: 26562320.
Lujan E, Pajon R, and Granoff DM. Impaired immunogenicity of meningococcal neisserial surface protein A in human complement factor H transgenic mice. Infection and Immunity 2015;84:452-458. PubMed ID: 26597984.
Granoff DM, Costa I, Konar M, Giuntini S, Van Rompay KK and Beernink PT. Binding of complement factor H (FH) decreases protective anti-FH binding protein antibody responses of infant rhesus macaques immunized with a meningococcal serogroup B vaccine. Journal of Infectious Diseases 2015;212:784-792. PubMed ID: 25676468.
Konar M, Beernink PT, and Granoff DM. A newly-identified polymorphism in rhesus macaque complement factor H modulates binding affinity for meningococcal FHbp. PLoS One 2015;10:e0135996. PubMed ID: 26285122.
Beernink PT, Giuntini S, Costa I, Lucas AH and Granoff DM. Functional analysis of the human antibody response to meningococcal factor H binding protein. mBio 2015;6:e00842. PubMed ID: 26106082.
Pajon R, Buckwalter CM, Johswich KO, Gray-Owen SD and Granoff DM. A native outer membrane vesicle vaccine confers protection against meningococcal colonization in human CEACAM1 transgenic mice. Vaccine 2015;33:1317-1323. PubMed ID: 25662856.
Granoff DM and Gilsdorf JR. Neisseria meningitidis (Meningococcus). In: Kliegman RM, Stanton B, St. Geme J, Schor N, and Behrman RE, editors. Nelson Textbook of Pediatrics. 19th ed. Philadelphia: Saunders Elsevier; 2012. p 929-935.
Revised: Thursday, July 6, 2017 9:45 AM